Thermo Fisher Scientific (BSP:TMOS34) ROC (Joel Greenblatt) %: 50.57% (As of Mar. 2026) — 17% Below Median


BSP:TMOS34 Thermo Fisher Scientific Inc BSP:TMOS34
74 GF Score
Price R$57.02
GF Value R$63.65
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific ROC (Joel Greenblatt) %?

Thermo Fisher Scientific BSP:TMOS34 +0.48% 74 ROC (Joel Greenblatt) % is 50.57% as of Mar. 2026, which is 17% below its 10-year median of 60.62. GuruFocus rates BSP:TMOS34 with a GF Score™ of 74/100 and a GF Value™ of R$63.65 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 211 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks better than 88.63% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Thermo Fisher Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 50.57%.

The historical rank and industry rank for Thermo Fisher Scientific's ROC (Joel Greenblatt) % or its related term are showing as below:

BSP:TMOS34' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 50.17   Med: 60.62   Max: 90.21
Current: 55.91

During the past 13 years, Thermo Fisher Scientific's highest ROC (Joel Greenblatt) % was 90.21%. The lowest was 50.17%. And the median was 60.62%.

BSP:TMOS34's ROC (Joel Greenblatt) % is ranked better than
88.63% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.02 vs BSP:TMOS34: 55.91

Thermo Fisher Scientific's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -9.10% per year.


Thermo Fisher Scientific  (BSP:TMOS34) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Thermo Fisher Scientific ROC (Joel Greenblatt) % Related Terms


Thermo Fisher Scientific ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific ROC (Joel Greenblatt) % Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.87 65.13 54.25 68.37 56.78

Thermo Fisher Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.77 53.66 53.22 63.33 50.57

BSP:TMOS34 vs DHR, IDXX, A: ROC (Joel Greenblatt) % Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific ROC (Joel Greenblatt) % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's ROC (Joel Greenblatt) % falls into.


BSP:TMOS34
74GF Score
Thermo Fisher Scientific Inc BSP:TMOS34
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(48555.73 + 29597.172 + 14244.834) - (48806.692 + 14784.947 + -1.4551915228367E-11)
=28806.097

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(48133.238 + 28741.882 + 13994.409) - (44990.249 + 15312.269 + 0)
=30567.011

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Thermo Fisher Scientific for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=43677.62/( ( (57639.47 + max(28806.097, 0)) + (55737.077 + max(30567.011, 0)) )/ 2 )
=43677.62/( ( 86445.567 + 86304.088 )/ 2 )
=43677.62/86374.8275
=50.57 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 50.57% mean?
Thermo Fisher Scientific (BSP:TMOS34) has a ROC (Joel Greenblatt) % of 50.57% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Thermo Fisher Scientific and its competitors. This is 17% below median its historical median of 60.62. Over the past decade, Thermo Fisher Scientific's ROC (Joel Greenblatt) % has ranged from 50.17 to 90.21. According to the industry distribution chart, Thermo Fisher Scientific ranks #24 out of 211 companies in the Medical Diagnostics & Research industry, placing it in the top 11.4%.
Is Thermo Fisher Scientific's ROC (Joel Greenblatt) % too high?
Thermo Fisher Scientific's current ROC (Joel Greenblatt) % of 50.57% is 17% below median its 10-year median of 60.62. Over the past 10 years, this metric has ranged from a low of 50.17 to a high of 90.21. Based on the distribution chart, Thermo Fisher Scientific ranks #24 out of 211 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Thermo Fisher Scientific has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's ROC (Joel Greenblatt) % compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #24 out of 211 companies for ROC (Joel Greenblatt) %. This places Thermo Fisher Scientific in the top 11% of its industry — outperforming the majority of peers. Historically, Thermo Fisher Scientific's own ROC (Joel Greenblatt) % has ranged from 50.17 to 90.21 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good ROC (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current ROC (Joel Greenblatt) % is 50.57%, which is 17% below median its own 10-year median of 60.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$63.65, compared to a current price of R$57.02 — trading 10.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 50.57%, which is 17% below median its 10-year median of 60.62. Thermo Fisher Scientific's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current ROC (Joel Greenblatt) % is 50.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued. The current stock price of R$57.02 is trading 10.4% below its estimated GF Value™ of R$63.65. GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.

Key valuation signals for BSP:TMOS34:

  • ROC (Joel Greenblatt) %: 50.57% (17% below median its 10-year median of 60.62)
  • GF Value™: R$63.65 vs. price of R$57.02 (10.4% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
74GF Score

Get the complete analysis for BSP:TMOS34

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$57.02
Price
R$63.65
GF Value